Sudeep Pharma (SUDEEPPHRM) Stock Overview

Manufactures and sells excipients and specialty ingredients for the pharmaceutical, food, and nutrition industries in United States, Europe, United Kingdom, and Latin America. More details

SUDEEPPHRM fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	2/6
Financial Health	5/6
Dividends	0/6

Rewards

Earnings have grown 29.1% per year over the past 5 years

Risk Analysis

High level of non-cash earnings

SUDEEPPHRM Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View Stock Community

Sudeep Pharma Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Sudeep Pharma
Historical stock prices
Current Share Price	₹546.75
52 Week High	₹795.00
52 Week Low	₹543.90
Beta	0
1 Month Change	-19.18%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-29.37%

Recent updates

Shareholder Returns

	SUDEEPPHRM	IN Chemicals	IN Market
7D	-8.4%	-1.8%	-2.8%
1Y	n/a	0.1%	3.8%

Return vs Industry: Insufficient data to determine how SUDEEPPHRM performed against the Indian Chemicals industry.

Return vs Market: Insufficient data to determine how SUDEEPPHRM performed against the Indian Market.

Price Volatility

Is SUDEEPPHRM's price volatile compared to industry and market?
SUDEEPPHRM volatility
SUDEEPPHRM Average Weekly Movement	n/a
Chemicals Industry Average Movement	4.8%
Market Average Movement	5.2%
10% most volatile stocks in IN Market	8.5%
10% least volatile stocks in IN Market	3.1%

Stable Share Price: Data is not available.

Volatility Over Time: Insufficient data to determine SUDEEPPHRM's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1989	480	Sujit Bhayani	www.sudeeppharma.com

Sudeep Pharma Limited manufactures and sells excipients and specialty ingredients for the pharmaceutical, food, and nutrition industries in United States, Europe, United Kingdom, and Latin America. The company provides mineral salts, such as calcium, zinc, iron, potassium, magnesium, sodium, and copper to a range of health-focused applications; and calcium carbonate, which is used as an active pharmaceutical ingredient for various therapeutic applications. It also offers micronutrient premixes, encapsulated ingredients, liposomal and spray-dried formats, granulated minerals, and triturated blends to meet the needs across functional foods, dietary supplements, infant and clinical nutrition, fast-moving consumer goods, and convenience food formulations.

Sudeep Pharma Limited Fundamentals Summary

How do Sudeep Pharma's earnings and revenue compare to its market cap?
SUDEEPPHRM fundamental statistics
Market cap	₹61.75b
Earnings (TTM)	₹1.49b
Revenue (TTM)	₹5.61b

41.3x

P/E Ratio

11.0x

P/S Ratio

Is SUDEEPPHRM overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SUDEEPPHRM income statement (TTM)
Revenue	₹5.61b
Cost of Revenue	₹2.04b
Gross Profit	₹3.57b
Other Expenses	₹2.07b
Earnings	₹1.49b

Last Reported Earnings

Sep 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)	13.23
Gross Margin	63.64%
Net Profit Margin	26.66%
Debt/Equity Ratio	19.1%

How did SUDEEPPHRM perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/01/09 16:36
End of Day Share Price	2026/01/09 00:00
Earnings	2025/09/30
Annual Earnings	2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sudeep Pharma Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Sudeep Pharma LimitedNSEI:SUDEEPPHRM Stock Report